leupeptin has been researched along with Becker Muscular Dystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, P; Barton, E; Carver, T; Pendrak, K; Pham, J; Selsby, J; Sweeney, HL; Tian, Z; Zadel, M | 1 |
| Badalamente, MA; Stracher, A | 1 |
2 other study(ies) available for leupeptin and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Leupeptin-based inhibitors do not improve the mdx phenotype.
Topics: Animals; Biomarkers; Calcium-Binding Proteins; Calpain; Creatine Kinase; Cysteine Proteinase Inhibitors; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Drug; Genotype; Leupeptins; Mice; Mice, Inbred mdx; Muscle Contraction; Muscle Strength; Muscular Dystrophy, Duchenne; Necrosis; Phenotype; Proteasome Endopeptidase Complex; Time Factors | 2010 |
Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition.
Topics: Animals; Calpain; Cysteine Proteinase Inhibitors; Histocytochemistry; Leupeptins; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Microscopy, Electron; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Necrosis | 2000 |